Target_Medical_Solutions_ - Accounts


Company Registration No. 08339516 (England and Wales)
Target Medical Solutions Ltd
Annual Report and Unaudited Financial Statements
For the Year Ended
31 March 2017
PAGES FOR FILING WITH REGISTRAR
TARGET MEDICAL SOLUTIONS LTD
Target Medical Solutions Ltd
COMPANY INFORMATION
Directors
Mr R F Smith
Mr D A Rees
Mr D J Byrne
Secretary
Mrs L Woodward
Company number
08339516
Registered office
Centaur House
Gardiners Place
SKELMERSDALE
Lancashire
WN8 9SP
Accountants
Montpelier Professional (Lancs) Limited
Charter House
Pittman Way
Fulwood
Preston
Lancashire
PR2 9ZD
TARGET MEDICAL SOLUTIONS LTD
Target Medical Solutions Ltd
CONTENTS
Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 7
TARGET MEDICAL SOLUTIONS LTD
Target Medical Solutions Ltd
STATEMENT OF FINANCIAL POSITION
AS AT
31 MARCH 2017
31 March 2017
- 1 -
2017
2016
as restated
Notes
£
£
£
£
Fixed assets
Property, plant and equipment
4
28,990
23,939
Current assets
Trade and other receivables
5
1,507,297
1,035,941
Cash and cash equivalents
157,778
119,609
1,665,075
1,155,550
Current liabilities
6
(1,774,672)
(1,351,488)
Net current liabilities
(109,597)
(195,938)
Total assets less current liabilities
(80,607)
(171,999)
Equity
Called up share capital
100
100
Retained earnings
(80,707)
(172,099)
Total equity
(80,607)
(171,999)
TARGET MEDICAL SOLUTIONS LTD
Target Medical Solutions Ltd
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT
31 MARCH 2017
31 March 2017
- 2 -

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

For the financial year ended 31 March 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.

The financial statements were approved by the board of directors and authorised for issue on 21 December 2017 and are signed on its behalf by:
Mr R F Smith
Director
Company Registration No. 08339516
TARGET MEDICAL SOLUTIONS LTD
Target Medical Solutions Ltd
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2017
- 3 -
1
Accounting policies
Company information

Target Medical Solutions Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Centaur House, Gardiners Place, SKELMERSDALE, Lancashire, WN8 9SP.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

These financial statements for the year ended 31 March 2017 are the first financial statements of Target Medical Solutions Ltd prepared in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland. The date of transition to FRS 102 was 1 April 2015. The reported financial position and financial performance for the previous period are not affected by the transition to FRS 102.

1.2
Revenue

Revenue represents amounts chargeable to clients for professional services inclusive of direct expenses incurred on client assignments but excluding value added tax. Revenue is recognised when a right to consideration has been obtained through performance under each contract,

 

Revenue is not recognised where the right to receive payment is contingent on events outside of the control of the company.

 

1.3
Property, plant and equipment

Property, plant and equipment are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer equipment
- 33% Straight Line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

TARGET MEDICAL SOLUTIONS LTD
Target Medical Solutions Ltd
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2017
1
Accounting policies
(Continued)
- 4 -
1.4
Impairment of non-current assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Recoverable amount is the higher of fair value less costs to sell and value in use. If the recoverable amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables are recognised at the settlement amount.

Basic financial liabilities

Basic financial liabilities, including trade and other payables, are recognised at their settlement amount after allowing for any trade discounts due.

 

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payables are classified as current liabilities if payment is due within one year or less.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

TARGET MEDICAL SOLUTIONS LTD
Target Medical Solutions Ltd
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2017
1
Accounting policies
(Continued)
- 5 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or non-current assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.9
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.10

Going concern

The financial statements have been prepared on a going concern basis. The company is technically insolvent at the balance sheet date with liabilities exceeding assets by £80,607. The directors are of the opinion that the company will continue in business in the foreseeable future with their continued support.

2
Prior year adjustments

A prior year adjustment has been done to reclassify and correct mis-posting identified relating to the year 2016.

In summary the adjustment are as follows:

 

     £

Adjustment for recognition of sales too early             143,046

Reallocation of costs to correct period              13,827

Tax adjustment as a consequence of the above         (31,958)

Total                             124,915

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was 24 (2016 - 17).

TARGET MEDICAL SOLUTIONS LTD
Target Medical Solutions Ltd
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2017
- 6 -
4
Property, plant and equipment
Plant and machinery etc
£
Cost
At 1 April 2016
32,388
Additions
19,885
At 31 March 2017
52,273
Depreciation and impairment
At 1 April 2016
8,449
Depreciation charged in the year
14,834
At 31 March 2017
23,283
Carrying amount
At 31 March 2017
28,990
At 31 March 2016
23,939
5
Trade and other receivables
2017
2016
as restated
Amounts falling due within one year:
£
£
Trade receivables
1,265,486
580,337
Other receivables
241,811
455,604
1,507,297
1,035,941
6
Current liabilities
2017
2016
as restated
£
£
Trade payables
719,269
437,690
Other taxation and social security
717,441
483,284
Other payables
337,962
430,514
1,774,672
1,351,488

 

TARGET MEDICAL SOLUTIONS LTD
Target Medical Solutions Ltd
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2017
- 7 -
7
Security

Barclays Bank PLC has a charge over monies deposited with the bank in respect of any loans owed by the company to the bank. At the year end there were no such loans.

2017-03-312016-04-01falseCCH SoftwareCCH Accounts Production 2017.300No description of principal activity21 December 2017083395162016-04-012017-03-3108339516bus:Director12016-04-012017-03-3108339516bus:Director22016-04-012017-03-3108339516bus:Director32016-04-012017-03-3108339516bus:CompanySecretary12016-04-012017-03-3108339516bus:RegisteredOffice2016-04-012017-03-31083395162017-03-31083395162016-03-3108339516core:OtherPropertyPlantEquipment2017-03-3108339516core:OtherPropertyPlantEquipment2016-03-3108339516core:CurrentFinancialInstruments2017-03-3108339516core:CurrentFinancialInstrumentscore:RestatedAmount2016-03-3108339516core:RestatedAmount2016-03-3108339516core:ShareCapital2017-03-3108339516core:ShareCapital2016-03-3108339516core:RetainedEarningsAccumulatedLosses2017-03-3108339516core:RetainedEarningsAccumulatedLossescore:RestatedAmount2016-03-3108339516core:ComputerEquipment2016-04-012017-03-310833951612016-04-012017-03-31083395162015-04-012016-03-3108339516core:OtherPropertyPlantEquipment2016-03-3108339516core:OtherPropertyPlantEquipment2016-04-012017-03-3108339516core:CurrentFinancialInstruments2016-03-3108339516bus:PrivateLimitedCompanyLtd2016-04-012017-03-3108339516bus:FRS1022016-04-012017-03-3108339516bus:AuditExemptWithAccountantsReport2016-04-012017-03-3108339516bus:SmallCompaniesRegimeForAccounts2016-04-012017-03-3108339516bus:FullAccounts2016-04-012017-03-31xbrli:purexbrli:sharesiso4217:GBP